Your search returned 4 results.

Results
	1.	Pertuzumab for the treatment of breast cancer: a safety review. [Review] MedStar authors: Swain, Sandra M PMID: 26982349 Year: 2016 Citation: Expert Opinion on Drug Safety. 15(6):853-63, 2016 Jun Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Gao J, Swain SM DOI: https://dx.doi.org/10.1517/14740338.2016.1167185 Add to cart (remove)
	2.	The Role of Angiotensin-Converting Enzyme Inhibitors and beta-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. [Review] MedStar authors: Barac, Ana PMID: 31960742 Year: 2020 Citation: Journal of the American Heart Association. 9(2):e015327, 2020 01 21. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Barac A, Brown SA, Okwuosa TM, Volgman AS DOI: https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 https://dx.doi.org/10.1161/JAHA.119.015327 Add to cart (remove)
	3.	Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials. MedStar authors: Blackburn, Matthew J Lynce, Filipa PMID: 29119354 Year: 2018 Citation: Breast Cancer Research & Treatment. 168(1):35-41, 2018 Feb. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Blackburn MJ, Cai L, Harris P, Isaacs C, Lynce F, Pohlmann PR, Rubinstein L, Wang H DOI: https://dx.doi.org/10.1007/s10549-017-4563-3 Add to cart (remove)
	4.	Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 23868905 Year: 2013 Citation: Annals of Oncology. 24(10):2630-5, 2013 Oct. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM DOI: http://dx.doi.org/10.1093/annonc/mdt274 Add to cart (remove)

Powered by Koha